MedPath

XSPIRE PHARMA, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

FDA:10
CANADA:1

Drug Approvals

Fenoprofen Calcium

Approval Date
Oct 13, 2023
FDA

NALFON

Approval Date
Oct 13, 2023
FDA

Ciprofloxacin and Fluocinolone Acetonide

Approval Date
Feb 2, 2023
FDA

Butalbital, Acetaminophen and Caffeine

Approval Date
Jan 18, 2022
FDA

TaperDex 6-day

Approval Date
Jan 18, 2022
FDA

TaperDex 12-day

Approval Date
Jan 18, 2022
FDA

TaperDex 7-day

Approval Date
Jan 18, 2022
FDA

DEXAMETHASONE 6-Day

Approval Date
Jan 18, 2022
FDA

Levamlodipine

Approval Date
Nov 18, 2021
FDA

Ciprofloxacin Otic

Approval Date
Jan 30, 2021
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.